Dario A. Paggiarino - Jun 14, 2021 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Chief Medical Officer
Signature
/s/ Ron Honig, Attorney-in-Fact
Stock symbol
EYPT
Transactions as of
Jun 14, 2021
Transactions value $
-$4,053
Form type
4
Date filed
6/15/2021, 05:04 PM
Next filing
Jun 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYPT Common Stock Options Exercise $0 +1.42K +12.25% $0.00 13K Jun 14, 2021 Direct
transaction EYPT Common Stock Tax liability -$4.05K -417 -3.2% $9.72 12.6K Jun 14, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Restricted Stock Units Options Exercise $0 -1.42K -100% $0.00* 0 Jun 14, 2021 Common Stock 1.42K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
F2 Vests in three annual installments beginning on 14-Jun-2019